Unknown

Dataset Information

Plasma proteomic signatures predict dementia and cognitive impairment.


ABSTRACT:

Introduction

Biomarker discovery of dementia and cognitive impairment is important to gather insight into mechanisms underlying the pathogenesis of these conditions.

Methods

In 997 adults from the InCHIANTI study, we assessed the association of 1301 plasma proteins with dementia and cognitive impairment. Validation was conducted in two Alzheimer's disease (AD) case-control studies as well as endophenotypes of AD including cognitive decline, brain amyloid burden, and brain volume.

Results

We identified four risk proteins that were significantly associated with increased odds (peptidase inhibitor 3 (PI3), trefoil factor 3 (TFF3), pregnancy associated plasma protein A (PAPPA), agouti-related peptide (AGRP)) and two protective proteins (myostatin (MSTN), integrin aVb5 (IT

SUBMITTER: Tanaka T 

PROVIDER: S-EPMC7210784 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature